Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Digital health tools tested to boost activity in metabolic syndrome patients

NCT ID NCT07236450

Disease control Sponsor: Andreia Lobo Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study explored whether using a mobile app and a Fitbit Inspire 3 tracker can help adults with metabolic syndrome become more physically active. One hundred participants were split into two groups: one used the digital tools plus usual care, the other received usual care alone. Researchers measured changes in physical activity, health markers like cholesterol and blood sugar, and how often people used the app. The goal was to see if such digital tools can be practically used in primary care to support healthier lifestyles.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mobile health application (Polis Saúde®) and wearable activity tracker (Fitbit Inspire 3)
What this could lead to
If it works, this could show that simple digital tools can help people with metabolic syndrome become more active and better manage their condition in everyday primary care.
What could go wrong
This is a small, completed study with 100 participants, so results may not apply to everyone. The app and tracker only encourage activity—they don't directly treat metabolic syndrome, and long-term benefits are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

100 people

The number who actually took part.

Started

Jul 2025

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older; * Diagnosed with metabolic syndrome; * Presence of at least one of the following ICPC-2 (International Classification of Primary Care - 2nd edition), used in primary health care:codes in the medical record: * T83 (Overweight) or T82 (Obesity), with waist circumference ≥ 94 cm (men) or ≥ 80 cm (women) * T89 (Non-insulin-dependent diabetes) * T93 (Lipid metabolism disorder: HDL \< 40 mg/dl for men, \< 50 mg/dl for women; or triglycerides ≥ 150 mg/dl) * K86 (Hypertension without complications) or K87 (Hypertension with complications); * Access to a smartphone compatible with the mobile application; * Does not currently use any physical activity monitoring device (e.g., pedometer, smartwatch, fitness tracker); * Willing and able to provide informed consent. Exclusion Criteria: * No scheduled medical appointments in the past three years; * Refusal to participate or withdraws consent; * Change of primary care unit during the study period; * Pregnant at the time of enrollment or becomes pregnant during the study; * Diagnosed mental incapacity that prevents answering questionnaires; * Does not own a smartphone; * Inability to use a mobile application; * Inability to use a physical activity tracking wristband.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Metabolic syndrome (METS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome Health Behavior metabolic syndrome X Motor Activity Patient Participation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Metabolic syndrome (METS)

Contacts and locations

Locations

  • USF Cruz de Celas

    Coimbra, Portugal, 3000-011, Portugal

More trials for these conditions

Other studies related to the condition(s) this trial covers.